Eric Loumeau
2019
In 2019, Eric Loumeau earned a total compensation of $3.5M as Interim Chief Financial Officer and General Counsel at ANAPTYSBIO, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $91,440 |
|---|---|
| Option Awards | $3,060,804 |
| Salary | $381,000 |
| Other | $8,322 |
| Total | $3,541,566 |
Loumeau received $3.1M in option awards, accounting for 86% of the total pay in 2019.
Loumeau also received $91.4K in non-equity incentive plan, $381K in salary and $8.3K in other compensation.
Rankings
In 2019, Eric Loumeau's compensation ranked 3,427th out of 13,971 executives tracked by ExecPay. In other words, Loumeau earned more than 75.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,427 out of 13,971 | 76th |
Division Manufacturing | 1,244 out of 5,701 | 78th |
Major group Chemicals And Allied Products | 426 out of 2,200 | 81st |
Industry group Drugs | 354 out of 1,886 | 81st |
Industry Pharmaceutical Preparations | 266 out of 1,398 | 81st |
Source: SEC filing on April 27, 2020.
Loumeau's colleagues
We found three more compensation records of executives who worked with Eric Loumeau at ANAPTYSBIO in 2019.